Drug profile · INN
cabozantinib s-malate
CABOMETYX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cabozantinib s-malate (CABOMETYX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN cabozantinib s-malate
Brand CABOMETYX
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is cabozantinib s-malate?
cabozantinib s-malate (CABOMETYX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cabozantinib s-malate?
CABOMETYX is a marketed brand name for cabozantinib s-malate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cabozantinib s-malate?
cabozantinib s-malate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.